Ancora Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Ancora Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-22,727	Closed	-$650K	–	633
2018 Q4	$650K	Buy	22,727 +8,330	+58%	+$237K	0.03%	363
2018 Q3	$402K	Sell	14,397 -39,693	-73%	-$1.12M	0.02%	532
2018 Q2	$1.51M	Sell	54,090 -20,901	-28%	-$560K	0.07%	269
2018 Q1	$1.86M	Buy	74,991 +61,991	+477%	+$1.51M	0.08%	239
2017 Q4	$315K	Buy	13,000 +3,000	+30%	+$79K	0.02%	521
2017 Q3	$276K	Buy	+10,000	New	+$267K	0.02%	562

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Ancora Advisors's NXTM Position: Q1 2019 in Review

Ancora Advisors sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 22,727 shares — an estimated $650K sold.

Ancora Advisors first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $1.86M in Q1 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Ancora Advisors reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Ancora Advisors sold 22,727 NxStage Medical Inc. shares in Q1 2019, an estimated $650K.
Ancora Advisors first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
Ancora Advisors's NxStage Medical Inc. position peaked at $1.86M in Q1 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Ancora Advisors's 13F filing for Q1 2019, filed 15 May 2019.